November 27, 2020

24X7 News Guru

The Real Time News

COVID-19 Vaccine | Bharat Biotech#39;s Covaxin reported adverse event during Phase 1 trials, trials not halted

The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccine ...

COVID-19 Vaccine | Bharat Biotech#39;s Covaxin reported adverse event during Phase 1 trials, trials not halted The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccine

%d bloggers like this: